StockConsultant
Posted - 2 hours ago
$PTCT PTC Therapeutics stock, great rally off the 22.73 support area. from Stocks to Watch at https://stockconsultant.com/?PTCT
CP2023
Posted - 23 hours ago
$PTCT 👍👍
Rileyr15R
Posted - 1 day ago
$XENE $PTCT LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?
IN0V8
Posted - 1 day ago
$PTCT Opportunity JP Morgan raises target price to $62 from $51
anachartanalyst
Posted - 2 days ago
$PTCT
https://anachart.com/wp-content/uploads/ana_temp/1732032108_soc-img.jpg
pgod
Posted - 2 days ago
$PTCT why up PM?
Nosh
Posted - 5 days ago
$PTCT small entry...
BioGLovesMe
Posted - 6 days ago
$PTCT Sell the news? Probably due to people realizing how rare AADC is and how even only a fraction of those pats will qualify for the gene therapy. MAYBE a dozen?
The big money makers will be sepiapterin and PTC-518, should they get approved. Also keep in mind they still aren't making a profit even after laying off close to a third of the company and selling part of the Evrysdi royalties. Oh yeah and Translarna losing marketing authorization in EU will result in a revenue hit of $200-300m a year once it gets finalized.
OpenOutcrier
Posted - 1 week ago
$PTCT (+3.3% pre) PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy - SI https://ooc.bz/l/48091
johnnygogogo
Posted - 1 week ago
$PTCT what time is the decision on Upstaza? cc: $CLPT
Fishcakes123
Posted - 1 week ago
$PTCT Here is my prediction and I am fully aware this may age like milk. Upstaza is likely to get approved despite the lack of evidence. Firstly, it has been approved in the EU, UK and Israel. Secondly, I read through the EMA report on why they voted in favour and they essentially said despite there not being loads of evidence (AADC is an extremely rare disease) PTCT did the best they could to produce data to obtain clinically and statistically meaningful results. Furthermore, there is high demand (median life expectancy is 10 years) which is entirely unmet as there are no other drugs for AADC. The adeno-viral vector has been used in other FDA approved drugs, hinting to safety despite a lack of conclusive data. Furthermore, Upstaza has produced the first and only data that it reverses the severe symptoms of AADC i.e., lack of motor control. Therefore, whilst the data is unclear, the lack of existing treatment and attempts by the firm to get as much AP means I think this will get approv
Scanners_Free
Posted - 1 week ago
$PTCT BEAT TOP AND BOTTOM
RonFarms
Posted - 10/30/24
$PTCT ^
Estimize
Posted - 10/28/24
Here’s what 3 Estimize analysts believe $PTCT will report for Q3 2024 EPS [Reporting 11/07 AMC]
http://www.estimize.com/intro/ptct?chart=hi
Chingying
Posted - 10/24/24
$PTCT 11/13/2024 FDA PDUFA date for drug: Upstaza gene therapy for AADC FDA granted priority review on May 15, 2024.
Doozio
Posted - 1 month ago
$PTCT Thursday 🐑 low TIL 🧠⏰♾️
BioGLovesMe
Posted - 1 month ago
$PTCT Up on bad news....weird. Translarna is a large portion of their revenue, and given how they're still hemorrhaging money in R&D after cutting all of their gene therapy and 80% of their small molecule work.....
DonCorleone77
Posted - 1 month ago
$PTCT PTC Therapeutics announces negative CHMP opinion on Translarna authorization PTC Therapeutics announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has maintained its negative opinion on the renewal of the conditional marketing authorization of Translarna for the treatment of nonsense mutation Duchenne Muscular Dystrophy, or nmDMD, following re-examination. The opinion will now be reviewed by the European Commission which is expected to decide on opinion adoption in approximately 67 days.
themacromindset
Posted - 1 month ago
$PTCT PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results
DonCorleone77
Posted - 1 month ago
$PTCT PTC announces FDA review date for NDA of sepiapterin PTC Therapeutics announced that the FDA has set a target regulatory action date of July 29, 2025, for the review of the New Drug Application, or NDA, for sepiapterin, consistent with a standard review timeline. The NDA was submitted with an indication for the treatment of pediatric and adult patients with phenylketonuria, or PKU, including all age groups and the full spectrum of disease subtypes. In addition, PTC announced that the results of the Phase 3 APHENITY trial were recently published in The Lancet, one of the most prestigious peer-reviewed medical journals. The sepiapterin NDA includes the results from the Phase 3 APHENITY trial discussed in The Lancet publication, as well as data from the ongoing APHENITY open-label extension study, which provides evidence of the durability of effect of sepiapterin and the ability of patients to liberalize their diet and still maintain control of phenylalanine levels. Sepiapterin, an oral formulation of synthetic sepiapterin, has a dual mechanism of action to increase activity of the phenylalanine hydroxylase enzyme. Phenylketonuria is a rare, inherited metabolic disease, which affects the brain. It is caused by a defect in the gene that helps create the enzyme needed to break down phenylalanine. If left untreated or poorly managed, phenylalanine - an essential amino acid found in all proteins and most foods - can build up to harmful levels in the body.
FlynancialAnalyst
Posted - 1 month ago
$PTCT $3.0B mc $XBI #ShortSqueeze screen result knocking on $40 level with volume above a fresh gold-cross Short float % careening to 1yr+ lows, pct of all funds long shares is at 1yr highs & rising TrendEdge.app/asset/PTCT
Chingying
Posted - 1 month ago
$PTCT FDA priority review granted 05/14/24. PDUFA 11/13/2024 for drug: Upstaza for AADC
StocktwitsNews
Posted - 1 month ago
PTC Therapeutics, Palladyne AI, WeightWatchers: Retail Most Bullish On These Stocks Pre-Market. $PTCT $PDYN $WW https://stevents.onelink.me/wmCS/sertgmzf
ChartLaboratory_com
Posted - 1 month ago
🔥 $SPAI bullish breakout in progress! Targeting $3.50 with support at $2.50. #StockMarket #Trading https://www.tradingview.com/x/dKGchBqA/ 📈 $PTCT charging up! Eyes on $45.00. Watch for entry at $39.00! #Stocks #DayTrading https://www.tradingview.com/x/92MEqijy/ 🚀 $VERI showing strength above $4.00. Next stop: $4.50! #SwingTrade #Investing https://www.tradingview.com/x/4xEWoS7r/ 📊 $PDYN on the rise with targets at $3.00. Ready to scalp? #Trading #StockWatch https://www.tradingview.com/x/vaJvMQDg/ 💡 $BURU breaking out with $1.25 on the horizon. Ideal for quick trades! #StockMarket #Bullish https://www.tradingview.com/x/WmZ58EQw/
Thestocktraderhubzee
Posted - 1 month ago
WATCHLIST OCT 09 2024..
$SOC BWS Financial Initiates Coverage On Sable Offshore with Sell Rating, Announces Price Target of $6
$PTCT Baird Reiterates Outperform on PTC Therapeutics, Maintains $44 Price Target
$RKT Barclays Maintains Underweight on Rocket Companies, Raises Price Target to $14
$MTG Barclays Maintains Equal-Weight on MGIC Investment, Raises Price Target to $24
$PDCO Evercore ISI Group Maintains In-Line on Patterson Cos, Lowers Price Target to $22
GambitMentality
Posted - 1 month ago
Today’s #StockMarket EOD Biggest Gainers by %, led by $DJT $MPLN and $PTCT to lead the TOP 3
Doozio
Posted - 1 month ago
$PTCT no faatch 💣 TIL 🧠⏰♾️
IsabellaDC
Posted - 1 month ago
Swing candidates: $PTCT $MIR $ALHC $GRND $SLNO (own)
PensionPulse
Posted - 1 month ago
$PTCT $BHVN Nice breakouts happening here, extremely bullish but will be volatile...
